APO010
APO010/P1/002
Phase 2 small_molecule terminated
Quick answer
APO010 for Relapsed/Refractory Multiple Myeloma is a Phase 2 program (small_molecule) at Allarity Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allarity Therapeutics
- Indication
- Relapsed/Refractory Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated